Track 21: HIV gene therapy

In patients with HIV, highly active antiretroviral therapy significantly increases survival. The existence of drug-resistant escape mutations, cumulative toxicities, and partial immunological recovery can make lifelong treatment more difficult as a result of the persistence of HIV in reservoirs. In the absence of long-term antiviral medication, cell and gene therapies hold the potential of avoiding progressive HIV infection by blocking HIV replication.


    Track 21: HIV gene therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in